Evidence map›Paper›PMID 34484342›Full record

ArticleInternational journal of analytical chemistry2021

A Rapid Screening Method for Sibutramine Hydrochloride in Natural Herbal Medicines and Dietary Supplements.

Qi Liang, Yue Zhuang, Jun Ma, Jinyan Wang, Rui Feng, Ruisi He, Zhuoya Luo, Honghao Wang, Ruoting Zhan

Open access · goldAbstract read
In one paragraph

Article in International journal of analytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Qi LiangGuangdong Institute for Drug Control, Guangzhou, China.ORCID https://orcid.org/0000-0001-6453-2952
Yue ZhuangGuangdong Institute for Drug Control, Guangzhou, China.
Jun MaGuangdong Institute for Drug Control, Guangzhou, China.
Jinyan WangGuangdong Institute for Drug Control, Guangzhou, China.
Rui FengResearch Center of Chinese Herbal Resource Science and Engineering, Guangzhou University of Chinese Medicine, Guangzhou, China.
Ruisi HeSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.
Zhuoya LuoGuangdong Institute for Drug Control, Guangzhou, China.ORCID https://orcid.org/0000-0003-3158-5366
Honghao WangMarket Regulation Administration of Guangdong, Guangzhou, China.
Ruoting ZhanSchool of Chinese Materia Medica, Ministry of Education, Key Laboratory of Chinese Medicinal Resource from Lingnan, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangdong Institute for Drug Control · CNGuangzhou University of Chinese Medicine · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herbal weight loss drugs are becoming more widely used in the fight against obesity, but ineffective regulation of these products have resulted in harmful additives. These products may contain adulterants such as sibutramine hydrochloride that may result in serious adverse health events including death. This work established a color precipitation reaction-based rapid screening method for illegal adulteration of sibutramine hydrochloride in natural herbal medicines (NHM) and dietary supplements (DS). While a variety of chromatography- and electrophoresis-based systems have been reported to measure this analyte, they generally suffer from high costs, complicated sample preparation, and a costly analytical infrastructure. In contrast, we present a simple, handheld kit to assay for sibutramine. The performance metrics of this tool include an average detection time of approximately 3 minutes, which is markedly shorter than conventional methods (HPLC or HPLC-MS, etc.), a detection limit of 0.1 mg per aliquot, and an accuracy of 99.02% (

Identifiers

PMID34484342
PMCPMC8413021
OpenAlexW3196934724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.